Benlysta Approved for Lupus

On March 9th, the FDA approved Benlysta for treatment of lupus.  Benlysta is the first new drug to be approved for systemic lupus erythematosus since 1955, and is designed to inhibit the maturation of B lymphocytes, the white blood cells which attack no… more »
PermalinkPermalink